Literature DB >> 16391382

Arterial remodeling correlates positively with serological evidence of inflammation in patients with chronic stable angina pectoris.

Stephen G Worthley1, H M Omar Farouque, James D Cameron, Ian T Meredith.   

Abstract

Positive coronary artery remodeling is associated with unstable coronary syndromes. Serum inflammatory markers, including high-sensitivity CRP (hsCRP), can predict future risk of acute coronary events in patients with stable coronary artery disease. We sought to elucidate the relationship of specific serum inflammatory markers with intravascular ultrasound (IVUS) estimation of coronary artery remodeling in patients with stable coronary artery disease. Thirty-one sequential patients at our institution undergoing IVUS-assisted percutaneous coronary intervention (PCI) with stable coronary artery disease were enrolled. Automated IVUS pullback and offline analysis were performed in all patients. Images were analyzed for vessel wall area (VWA) and lumen area (LA), at the culprit lesion and at a proximal reference site, and the remodeling index (RI) was calculated. Positive and negative remodeling were defined as a RI of > 1.05 and < 0.95, respectively. ELISA essays were performed for soluble VCAM-1, ICAM-1 and E-selectin. The distribution of data followed a lognormal distribution. By defining arterial remodeling as simply positive or negative, significant differences were identified for log E-selectin only (1.80 +/- 0.04 versus 1.62 +/- 0.05, respectively; p = 0.02). The RI correlation coefficient was 0.38 (p = 0.04) for log sVCAM-1 and 0.42 (p = 0.02) for log sICAM-1. The log E-selection and RI correlation coefficient, although weaker at 0.32, showed a trend toward significance (p = 0.08). There was no significant correlation between log hsCRP and RI (p = 0.42). Using step-wise multivariate analysis, log sVCAM-1 only remained an independent predictor of the RI (p = 0.03). Positive coronary artery remodeling correlates with serological markers of inflammation in patients with stable coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391382

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  5 in total

1.  Innate immunity has a dual effect on vascular healing: suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge.

Authors:  H Epstein; E Grad; M Golomb; N Koroukhov; E R Edelman; G Golomb; H D Danenberg
Journal:  Atherosclerosis       Date:  2007-12-11       Impact factor: 5.162

2.  sICAM-1 measurements are independent of processing method and sampling site in patients with coronary artery disease.

Authors:  V L Benson; A C McMahon; H C Lowe
Journal:  J Thromb Thrombolysis       Date:  2007-03-31       Impact factor: 2.300

3.  Traditional and nontraditional cardiovascular risk factors in comorbid insomnia and sleep apnea.

Authors:  Faith S Luyster; Kevin E Kip; Daniel J Buysse; Aryan N Aiyer; Steven E Reis; Patrick J Strollo
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

4.  Brachial artery diameter, blood flow and flow-mediated dilation in sleep-disordered breathing.

Authors:  Hassan A Chami; Michelle J Keyes; Joseph A Vita; Gary F Mitchell; Martin G Larson; Shuxia Fan; Ramachandran S Vasan; George T O'Connor; Emelia J Benjamin; Daniel J Gottlieb
Journal:  Vasc Med       Date:  2009-11       Impact factor: 3.239

Review 5.  CRP and the risk of atherosclerotic events.

Authors:  Paolo Calabrò; Enrica Golia; Edward T H Yeh
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.